לוח משרות דרושים ביוטכנולוגיה במרכז

Cell Therapy Quality Control Specialist Flow Cytometry
Advanced Biotherapy Center
Sheba Medical Center, Tel Hashomer
We are looking for a highly motivated individual to perform analytic assays for experimental cell and gene therapies for patients in clinical trials. Your main focus will be on designing and performing flow cytometery assays. You will also perform assays using various techniques including qPCR, ddPCR, ELISA, and bacterial culture.
You will work with various TEST materials including viral vectors, cell banks, primary human cells, and human blood. You will be part of a small team performing required QC assays for both Sheba projects and outside customers. Experience with analytic assays and cell culture in biotech, or pharma laboratory is preferred.
Excellent written English is required. This work may lead to publications in scientific journals and will support clinical trials for treatment of patients with cancer and other types of disease.
Sheba Medical Center is developing and manufacturing new cell and gene therapies for patients with serious diseases. The job holder will report to Dr. Jonathan Esensten at Sheba Medical Center.

We are hiring a Bioinformatician to join Nucleai’s team. A cancer patient wants to know that their diagnosis and treatment are determined with the greatest precision and preferably using the most advanced technology. At Nucleai, we bring cancer patients cutting-edge AI-based technology by improving biopsy interpretation with machine learning and creating novel precision medicine technology. Come join our team of experienced AI engineers and world-renowned clinicians, and help us make a difference. At Nucleai, we believe that talents are our most valued asset, and as such, hiring the right people is one of our most strategic missions. Responsibilities
* Supports the full life cycle of spatial data: spatial feature design, data quality control, differential expression analysis, biological interpretation of results, and delivery.
* Ensures timely and proper analysis of spatial data generated by digital pathology.
* Maintains or develops new functionality for bioinformatics pipelines to analyze and visualize spatial data.
* Collaborates on a variety of spatial biology projects.

Required Analyst
Job Description:
A clinical-stage drug discovery and development company in the field of cancer immunotherapy. In line with our business model to enter into collaborations for their internally discovered, novel therapeutic candidates at various stages in research and development, the company is seeking an Analyst in support of its partnering efforts.
Reporting to the SVP Strategic Collaborations, the Analyst will lead competitive intelligence (CI) and business analysis activities to support BD and corporate objectives. She/he will be responsible for supporting aspects of competitive analysis and other activities relating to partnering efforts.
Constantly monitor the pharma and biotech space and gather competitive intelligence from various sources including company portfolios, preclinical and clinical activities, scientific data, partnerships, deal structures and terms, and other relevant intelligence
Perform analyses and provide insights into competitive landscapes, industry trends and perspectives, market developments, product developments and positioning, as well as other intelligence in support of our BD&L and R&D efforts
Provide regular updates to our management and functions
Develop Target Product Profiles for our development candidates in close collaboration with R&D teams, and build forecast models based on epidemiological data as well as customer/patient segmentation, pricing and access assumptions
Identify potential collaboration partners for various pipeline opportunities
Work closely with our R&D community and drive the preparation of materials surrounding the companys pipeline programs for internal presentation to management and also to potential partners
Contribute to the creation of valuation models and financial valuation of business development opportunities against partnering scenarios.